Navigation Links
Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010
Date:6/26/2010

antidiabetes therapies,"(i) said Orville G. Kolterman, M.D., senior vice president, chief medical officer, Amylin Pharmaceuticals. "The study suggested that cases of pancreatitis in past BYETTA users may be related to other risk factors, such as gall stones, past acute pancreatitis and obesity."

Amylin and Lilly are continuing work to better understand the relationship between BYETTA and pancreatitis described in some spontaneously reported cases. In keeping with the companies' focus on patient safety, Amylin and Lilly continue to pursue a drug safety program that includes thorough investigation of individual spontaneous case reports along with clinical and epidemiologic studies. Patients and healthcare professionals should refer to product labeling for guidance regarding the use of BYETTA.

Study Design and Findings

Eligible patients were enrolled in the healthcare plan for at least a continuous nine-month baseline period with no history of chronic or acute pancreatitis prior to initiation of a new antidiabetic therapy. Adjudication of 652 claims-identified acute pancreatitis cases resulted in 40 confirmed acute pancreatitis cases in the BYETTA initiators and 254 confirmed cases in the other antidiabetic drug initiators. The NCCS analysis incorporated covariates (claims- and chart-derived) temporally related to acute pancreatitis occurrence to account for differences in the prevalence of risk factors between patients who persisted on or discontinued the study drugs.  

About Diabetes

Diabetes affects more than 24 million people in the U.S. and an estimated 285 million adults worldwide.(ii,iii) Approximately 90-95 percent of those affected have type 2 diabetes. Diabetes is the fifth leading cause of death by disease in the U.S. and costs approximately '/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Depth charge: Using atomic force microscopy to study subsurface structures
2. Effective Odor and Pathogen Control in Livestock Operations Revealed in New Case Study
3. Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
4. Independent Study Reveals dabl System Leads the way in Accurate Cardiovascular Diagnosis
5. ChemoCentryx Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR)
6. DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment
7. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
8. Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study
9. Onyx Pharmaceuticals Initiates Phase 1 Study of Oral Proteasome Inhibitor in Advanced Solid Tumors
10. Two-Year Follow up Data of NuBac® IDE Feasibility Study Was Presented at SAS Meeting
11. Reaction Progress Kinetic Analysis to Study Organic Reactions: Free On-Demand Online Seminar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 /CNW/ - Sunovion Pharmaceuticals Canada ... TM (eslicarbazepine acetate) for use as a once-daily ... patients with epilepsy who are not satisfactorily controlled with ... use in patients under 18 years of age. ... neurological disorders and according to Epilepsy Canada, it affects ...
(Date:7/10/2014)... Women in the West African ... additional family planning option. Sayana® Press has the ... levels of the health system and in communities ... used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with the BD ... first of four African countries expected to begin ...
(Date:7/10/2014)... July 10, 2014 Understanding the need ... cell lines, and the gap that currently exists in ... expand its industry-leading portfolio of validated ion channel and ... channel-expressing cell lines, as ion channels control many critical ... this activity creates the potential to treat a variety ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Robert Harman, DVM, ... Medicine company, is proud to announce the relaunch of his ... with a new series called “ What are Stem Cells ... an honest and straightforward foundation in the basics of stem ... decision on the right type of treatment when considering regenerative ...
Breaking Biology Technology:Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3
... PHOENIX, Nov. 12 Arizona Heart Innovative Technologies,LLC (AHIT) ... endovascular,use to a publicly traded medical device company. "This ... the past ten months. We,continue to demonstrate our ability ... community to commercially viable products for medical,device companies. This ...
... Zentaris Inc.,(NASDAQ: AEZS , TSX: AEZ), a ... will announce its third quarter 2008,financial and operating ... a.m.,The Company will host a conference call and ... at 10:00 a.m., Eastern Time., Participants may ...
... Novavax, Inc.,(Nasdaq: NVAX ) a clinical-stage vaccine ... Executive Officer, will be presenting at,the Lazard Capital Markets ... 19, 2008 at the St. Regis Hotel, New York ... strategy, research and,development progress. A link to the live ...
Cached Biology Technology:Arizona Heart Innovative Technologies Licenses New Endovascular Device 2
(Date:7/11/2014)... including scientists from the Max Planck Institute for Medical ... step in understanding photosynthesis, the process by which the ... its atmosphere and which is therefore crucial for all ... researchers report the first direct visualization of a crucial ... which a specific protein complex, photosystem II, splits water ...
(Date:7/11/2014)... 11, 2014 Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
(Date:7/11/2014)... has demonstrated that transplantation of mesenchymal stem cells can ... mouse models of Alzheimer,s disease (AD) and improve tissue ... Few studies are reported on the therapeutic effect of ... and on the effect on oxidative injury and neurogenesis ... and her team, School of Life Sciences, Tsinghua University, ...
Breaking Biology News(10 mins):A first direct glimpse of photosynthesis in action 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... ill, or suffered an injury, you,ve watched gloomily as your ... about as common to the human condition as breathing. ... causes skeletal muscles to atrophy. They know proteins are responsible, ... key actors from the poseurs is tricky. In a ...
... the atmosphere are rising; the average temperatures of the ... these changes. The transitional zones between shallow shelf seas ... huge amount of methane hydrates in the sea bed. ... and under high pressure. When the water temperature directly ...
... linked to type 2 diabetes have been discovered by an ... The study provides a fuller picture of the genetics ... patterns emerging. The international team, led by researchers ... and MIT, and the University of Michigan, Ann Arbor, used ...
Cached Biology News:Researchers identify key culprit causing muscle atrophy 2Researchers identify key culprit causing muscle atrophy 3Are methane hydrates dissolving? 210 new diabetes gene links offer picture of biology underlying disease 210 new diabetes gene links offer picture of biology underlying disease 3
2,4-Dinitrophenyl hapten is conjugated to Keyhole Limpet (KLH) protein through lysine....
IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml...
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is ...
ANTI GELSOLIN...
Biology Products: